rss
J Clin Pathol 2001;54:81-83 doi:10.1136/jcp.54.2.81

Immunology of chronic mucocutaneous candidiasis

  1. D Lilic,
  2. I Gravenor
  1. Department of Microbiology and Immunology, The Medical School, University of Newcastle, Framlington Place, Newcastle NE2 4HH, UK desa.lilic@ncl.ac.uk

      Patients with chronic mucocutaneous candidiasis (CMC) are susceptible to debilitating, persistent, and refractory infections of the skin, nails, and mucous membranes with yeasts of the genus candida, most often by the species Candida albicans. The underlying defect is thought to be an impairment of immune defences but the nature of the defect(s) has not been defined.1 Candida albicans is an opportunistic yeast inhabiting, as a commensal, the mucous membranes of > 80% of adults, becoming invasive only if the existing balance is disrupted. Various non-immunological factors are known to predispose to candida overgrowth and thrush (diabetes, obesity, systemic antibiotics, systemic and local steroid treatment, dentures, and occlusion—for example, nappies and tight clothing, etc); however, these infections are characteristically resolved as soon as the predisposing factors are removed and should not be confused with a persistent inability to clear candida, as is seen in CMC.2 Patients with CMC do not constitute a homogenous group and numerous classifications have been proposed, mostly based on the presence or absence of endocrinopathy, juvenile or mature onset, and familial or sporadic occurrence.3 Associated findings include alopecia, vitiligo, malabsorption disorders, and infections with encapsulated microorganisms.4 Patients with CMC and endocrinopathy are now frequently referred to as having the APECED (autoimmune polyendocrinopathy candidiasis ectodermal dysplasia) syndrome,5 previously known as APS-1 (autoimmune polyendocrinopathy syndrome type 1). In these patients, a genetic defect has recently been identified showing (various) mutations in the AIRE (autoimmune regulator) gene, which probably encodes a DNA transcription factor. The link between the identified gene defect and the inability to clear candida remains unknown. No gene defect has as yet been identified in patients with CMC without endocrinopathy, although there have been occasional reports of such patients where multiple family members through several generations were affected, again suggesting an …

      Latest from JCP Education

      Latest from JCP Education

      Register for free content


      Free sample
      This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
      View free sample issue >>

      Free archive
      The full back archive is now available for JCP. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

    • Latest Pathology jobs

      Latest Pathology jobs